SMX (Security Matters) Public Limited Company — Form 6-K Summary
Reporting period: December 2023; filed December 7, 2023. The filing reports a warrant inducement transaction rather than operating results for a quarterly or annual reporting period.
Transaction and Key Financial Terms
- Existing warrant holders agreed to exercise warrants for 606,060 ordinary shares for cash at a reduced exercise price of $1.15 per share, compared with the prior exercise price of $5.28 per share.
- Expected gross proceeds are approximately $696,969, before transaction fees and expenses. Net proceeds are intended for general corporate and working capital purposes.
- Before the transaction, SMX had approximately 3,946,081 ordinary shares outstanding.
- In exchange, SMX agreed to issue new warrants covering up to 909,090 ordinary shares.
- The New Warrants may be exercised beginning January 30, 2024 and expire five years after issuance.
- At the holders’ discretion, the exercise price is either $0.0022 per share for up to 75% of the warrant shares or $1.15 per share for the applicable warrant shares. The filing does not state how holders will allocate exercises between these alternatives.
- The New Warrants include customary adjustment provisions, ownership limitations generally capped at 4.99% or, at the holder’s election, 9.99%, and certain cash-payment obligations upon an exercise failure.
Material Changes and Potential Dilution
- The transaction provides near-term cash funding but increases the potential share count through the issuance of 606,060 shares upon Existing Warrant exercise and up to 909,090 additional shares upon New Warrant exercise.
- Relative to the approximately 3,946,081 pre-transaction shares outstanding, the 606,060 shares issuable from Existing Warrants represent approximately 15.4% additional shares, before considering the New Warrants.
- If all New Warrants are exercised, the potential additional shares represent approximately 23.0% of the pre-transaction share count. Actual dilution will depend on exercise decisions and future share issuances.
- The transaction was expected to close on or about December 8, 2023, subject to customary closing conditions; the filing does not confirm that closing occurred.
Registration, Financing Restrictions, and Liquidity
- The shares issuable upon Existing Warrant exercise are covered by an effective Form F-1 registration statement.
- SMX agreed to file a resale registration statement for the New Warrant shares within 15 days after closing and seek effectiveness within 45 calendar days after closing.
- For 45 days after closing, SMX agreed, subject to exceptions, not to issue additional ordinary shares or equivalents or file another registration statement.
- SMX agreed not to conduct or agree to conduct a variable-rate transaction for one year after closing, subject to an exception.
- For one year after closing, the holders generally receive a right to participate in certain subsequent equity, debt, or other financings on the same terms.
- No established trading market exists for the New Warrants, and SMX does not intend to list them. Their liquidity is therefore expected to be extremely limited.
Outlook, Risks, and Unusual Items
- Management’s stated use of proceeds is general corporate and working capital needs; the filing provides no detailed operating guidance or forecast.
- The low potential exercise price of $0.0022 could result in significant dilution if exercised for the permitted portion of the New Warrant shares.
- The New Warrants were issued in reliance on the Securities Act Section 4(a)(2) exemption and, along with the underlying shares, were not registered at issuance. Resales require registration or an applicable exemption.
- Holders receive participation rights for dividends or distributions on ordinary shares but generally have no shareholder voting rights before exercise.
- The New Warrants contain protections in fundamental transactions and may be amended or waived with written consent of SMX and the holders.
- The filing does not provide revenue, profit, cash-flow, margin, debt, or liquidity-balance information beyond the expected proceeds from this transaction.
Investor Verification Items
- Confirm whether the transaction closed and whether SMX received the stated approximately $696,969 gross proceeds.
- Verify the actual number of Existing Warrants exercised and ordinary shares issued.
- Review the final New Warrant documents to confirm the allocation mechanics between the $0.0022 and $1.15 exercise-price alternatives.
- Check the filing and subsequent reports for the required resale registration statement and its effectiveness.
- Assess potential dilution from both the 606,060 issued shares and the 909,090 New Warrant shares, together with any later financing or equity issuance.